South America Structural Heart Devices Market Research Report: Size, Share, Trend Analysis By Types (Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems), By Indication (Valvular Heart Disease, Cardiomyopathy), By Procedure (Replacement Procedures, Repair Procedures) andBy Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth Outlook & Industry Forecast 2025 To 2035
As per Market Research Future analysis, the South America structural heart-devices market Size was estimated at 77.0 $ Million in 2024. The South America structural heart-devices market is projected to grow from 82.06 $ Million in 2025 to 155.0 $ Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6.5% during the forecast period 2025 - 2035
The South America structural heart-devices market is poised for substantial growth driven by technological advancements and increasing patient awareness.
| 2024 Market Size | 77.0 (USD Million) |
| 2035 Market Size | 155.0 (USD Million) |
| CAGR (2025 - 2035) | 6.57% |
Edwards Lifesciences (US), Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Cardinal Health (US), LivaNova (GB), Terumo Corporation (JP), JenaValve Technology (DE), AtriCure (US)
Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry
The structural heart-devices market is currently experiencing notable growth, driven by advancements in technology and increasing awareness of heart diseases. In South America, the demand for innovative treatment options is rising, as healthcare providers seek to improve patient outcomes. The region's aging population and the prevalence of cardiovascular conditions are contributing factors to this trend. Furthermore, government initiatives aimed at enhancing healthcare infrastructure are likely to support the expansion of this market. As a result, manufacturers are focusing on developing cutting-edge devices that cater to the specific needs of patients in South America. In addition, the regulatory environment in South America is evolving, which may facilitate the introduction of new products. Collaboration between local and international companies is becoming more common, fostering innovation and improving access to advanced therapies. The structural heart-devices market appears poised for further growth, as stakeholders recognize the importance of addressing the unique challenges faced by the region. Overall, the combination of technological advancements, demographic shifts, and supportive policies suggests a promising future for this market in South America.
The structural heart-devices market is witnessing rapid technological advancements, with innovations in device design and materials. These developments enhance the efficacy and safety of treatments, making them more appealing to healthcare providers and patients alike. As a result, the market is likely to see an influx of new products that address specific cardiovascular conditions.
There is a growing awareness among patients regarding heart health and available treatment options. Educational campaigns and outreach programs are helping to inform the public about the benefits of structural heart devices. This trend may lead to increased demand for these devices, as more individuals seek proactive solutions for their cardiovascular issues.
The regulatory landscape for the structural heart-devices market in South America is evolving, with governments implementing policies that encourage innovation and streamline approval processes. This supportive environment may facilitate the entry of new products into the market, ultimately benefiting patients and healthcare providers.
Investment in healthcare infrastructure across South America is fostering growth in the structural heart-devices market. Governments and private entities are increasingly allocating funds to enhance healthcare facilities, which includes the procurement of advanced medical technologies. For instance, Brazil and Argentina have initiated programs to modernize hospitals and clinics, thereby improving access to cutting-edge treatments. This investment is expected to increase the availability of structural heart devices, making them more accessible to patients. The structural heart-devices market stands to benefit from these developments, as enhanced infrastructure will facilitate the adoption of innovative therapies and improve overall patient care.
The rising emphasis on preventive healthcare in South America is shaping the structural heart-devices market. As awareness of cardiovascular health grows, more individuals are seeking regular check-ups and screenings, leading to earlier detection of heart conditions. This proactive approach is likely to increase the demand for structural heart devices, as patients diagnosed with heart issues may require interventions. The structural heart-devices market is thus poised to benefit from this shift, as healthcare providers adapt to meet the needs of a more health-conscious population. Additionally, public health campaigns aimed at educating citizens about heart health are expected to further drive demand for these devices.
Technological innovations in the design and functionality of structural heart devices are propelling the market forward in South America. Advances in materials science and engineering have led to the development of devices that are not only more effective but also safer for patients. For instance, the introduction of bioresorbable materials and improved delivery systems has enhanced the performance of these devices. The structural heart-devices market is likely to see continued growth as manufacturers invest in research and development to create next-generation products. This focus on innovation is essential for meeting the evolving needs of healthcare providers and patients alike, ensuring that the market remains competitive and responsive.
The increasing prevalence of cardiovascular diseases in South America is a primary driver for the structural heart-devices market. According to health statistics, cardiovascular diseases account for approximately 30% of all deaths in the region. This alarming trend necessitates advanced medical interventions, including structural heart devices, to manage and treat these conditions effectively. As healthcare systems strive to improve patient outcomes, the demand for innovative solutions is likely to rise. Furthermore, the aging population in South America, which is projected to grow significantly, will further exacerbate the need for these devices. The structural heart-devices market is thus positioned to expand as healthcare providers seek to address the growing burden of cardiovascular diseases.
The shift towards minimally invasive procedures is significantly influencing the structural heart-devices market in South America. Patients and healthcare providers are increasingly favoring these techniques due to their associated benefits, such as reduced recovery times and lower complication rates. As a result, there is a growing demand for devices that can be deployed through less invasive methods. The structural heart-devices market is responding to this trend by developing products that align with these preferences. For example, transcatheter heart valves and closure devices are gaining traction, as they offer effective solutions with minimal patient discomfort. This trend is likely to continue, driving innovation and growth in the market.
In the South America structural heart-devices market, Transcatheter Aortic Valve Replacement (TAVR) currently holds the largest share among the various device types. Following this, Mitral Valve Repair Devices are gaining traction, attributed to their rising acceptance among healthcare providers and patients alike. Other notable mentions include Left Atrial Appendage Closure Devices and Transcatheter Pulmonary Valve, which also play significant roles in shaping the landscape of structural heart interventions.
Growth trends in this segment are primarily driven by an aging population with increasing incidences of heart diseases. Additionally, technological advancements and improved healthcare infrastructure are contributing factors. The demand for minimally invasive procedures is on the rise, as patients favor quicker recovery times and reduced hospital stays, further supporting the growth of Mitral Valve Repair Devices in particular, which is noted for its innovative solutions in cardiac care.
Transcatheter Aortic Valve Replacement (Dominant) vs. Mitral Valve Repair Devices (Emerging)
Transcatheter Aortic Valve Replacement (TAVR) is recognized as the dominant force in the market, owing to its effectiveness in treating aortic stenosis through a minimally invasive approach. Its widespread adoption is backed by robust clinical evidence showcasing excellent patient outcomes and reduced recovery time. In contrast, Mitral Valve Repair Devices are emerging as a strong competitor, driven by innovations aimed at enhancing procedural efficacy and patient safety. With increasing approvals for a variety of techniques and tools, including clips and rings designed for repairing mitral valves, this segment is rapidly expanding. The combined focus on improving patient quality of life and the ongoing clinical trials supporting innovative approaches contribute to the growing significance and market presence of these devices.
In the South America structural heart-devices market, the distribution of market share among the procedure types reveals that Minimally Invasive techniques command the largest share, reflecting a strong preference among patients and providers for less invasive options. Surgical procedures, while historically significant, are currently experiencing swift growth as advancements in surgical technology and techniques enhance their appeal.
Growth trends indicate a shift towards Minimally Invasive procedures driven by factors such as enhanced patient recovery times and decreased hospitalization durations. Surgical procedures, however, are becoming the fastest-growing segment, credited to emerging techniques and increasing investments in surgical capabilities. The evolving regulatory landscape is also fostering innovation and expanding access, further propelling the growth of both segments.
Minimally Invasive (Dominant) vs. Surgical (Emerging)
The Minimally Invasive segment is characterized by its focus on techniques that reduce patient trauma while delivering effective outcomes. This segment has become dominant due to its ability to provide quicker recovery times and less postoperative discomfort, appealing significantly to patients and healthcare providers. On the other hand, the Surgical segment, though historically established, is labeled as emerging due to innovations like robotic-assisted surgeries that enhance precision and safety. This segment's growth is fueled by increasing clinical success rates and an expanding population requiring complex interventions. Both segments are crucial in shaping the landscape of heart-device procedures in South America, with Minimally Invasive approaches leading in preference.
In the South America structural heart-devices market, the indication segment showcases Aortic Stenosis as the largest segment, commanding a significant share compared to Mitral Regurgitation and other indications like Heart Failure and Pulmonary Valve Stenosis. This distribution highlights the critical clinical need and treatment focus on Aortic Stenosis among healthcare providers, making it a primary consideration in interventional strategies.
Growth trends indicate that Mitral Regurgitation is emerging as the fastest-growing segment due to rising incidences and increased awareness about treatment options. Enhanced technology and innovative surgical techniques are driving this growth, alongside a focus on patient outcomes. Factors such as an aging population and heightened prevalence of heart diseases contribute to the expanding market, particularly in Mitral Regurgitation treatments.
Aortic Stenosis (Dominant) vs. Mitral Regurgitation (Emerging)
Aortic Stenosis remains the dominant indication in the South America structural heart-devices market, driven by its higher prevalence and critical patient outcomes associated with untreated cases. The traditional treatment options have evolved to include transcatheter aortic valve replacement (TAVR), which has gained widespread acceptance. On the other hand, Mitral Regurgitation is becoming an emerging segment, propelled by increasing awareness and advancements in minimally invasive approaches. The growing focus on heart failure treatments and the introduction of innovative devices are enhancing patient care options. As a result, while Aortic Stenosis holds a significant market share, Mitral Regurgitation is rapidly gaining ground, indicating a shift in treatment paradigms.
In the structural heart-devices market, hospitals account for a significant share due to their extensive resources and capabilities to handle complex surgeries. They dominate the market, providing advanced surgical procedures and specialized care for patients with structural heart diseases. On the other hand, ambulatory surgical centers, while valuable, play a smaller role compared to the comprehensive services offered by hospitals. Cardiology clinics are gaining traction as key players, focusing on prevention, diagnosis, and management of heart diseases, thus contributing to their emerging market presence.
Growth trends indicate an increasing preference for less invasive procedures and enhanced technological advancements in devices, which are driving the expansion of cardiology clinics. As awareness of heart disease rises, more patients seek specialized care, pushing cardiology clinics to adopt innovative device technologies rapidly. The demand for outpatient treatments further propels this growth, as patients prefer facilities that provide timely and efficient services, making clinics an increasingly important segment in the market.
Hospitals (Dominant) vs. Cardiology Clinics (Emerging)
Hospitals are the dominant segment in the structural heart-devices market, primarily because they provide comprehensive treatment options and have state-of-the-art surgical facilities capable of performing complex procedures. Their extensive infrastructure, coupled with a wide range of specialists, allows hospitals to deliver advanced care effectively. In contrast, cardiology clinics are emerging rapidly, focusing on outpatient services and preventive care for heart diseases. They offer personalized treatment plans and utilize the latest device technology, attracting a growing patient base. The trend toward minimally invasive procedures aligns with their service model, making them increasingly relevant in the landscape of heart health. As the market shifts towards outpatient care, cardiology clinics are positioned to capture a larger share, complementing the established role of hospitals.
Get more detailed insights about South America Structural Heart Devices Market Request Free Sample
Brazil holds a commanding 35.0% market share in South America's structural heart-devices market, valued at approximately $1.5 billion. Key growth drivers include an aging population, increasing prevalence of cardiovascular diseases, and government initiatives aimed at improving healthcare access. Regulatory policies are becoming more favorable, with the National Health Surveillance Agency (ANVISA) streamlining approval processes for innovative devices, enhancing market dynamics. Infrastructure improvements in healthcare facilities further support demand trends, particularly in urban areas. Key markets include São Paulo, Rio de Janeiro, and Brasília, where advanced healthcare infrastructure is concentrated. The competitive landscape features major players like Edwards Lifesciences, Medtronic, and Abbott Laboratories, all of which have established a strong presence. Local dynamics are characterized by a growing emphasis on minimally invasive procedures, with hospitals increasingly adopting advanced technologies. The business environment is bolstered by partnerships between local firms and international manufacturers, enhancing product availability and innovation.
Mexico accounts for 20.0% of the structural heart-devices market in South America, valued at around $800 million. The market is driven by increasing healthcare investments, a growing middle class, and rising awareness of cardiovascular health. Demand trends indicate a shift towards advanced technologies, supported by government initiatives to enhance healthcare infrastructure. Regulatory frameworks are also improving, facilitating faster access to innovative devices for patients across the country. Key markets include Mexico City, Guadalajara, and Monterrey, where healthcare facilities are rapidly modernizing. The competitive landscape features significant players like Boston Scientific and Medtronic, which are investing in local manufacturing. The business environment is favorable, with a growing number of partnerships between local hospitals and international firms. The focus on preventive care and early diagnosis is driving the adoption of structural heart devices, making Mexico a promising market for future growth.
Argentina holds a 12.0% share of the structural heart-devices market in South America, valued at approximately $500 million. Key growth drivers include an increasing incidence of heart diseases and a rising demand for advanced medical technologies. Government initiatives aimed at improving healthcare access and affordability are also contributing to market expansion. Regulatory policies are evolving, with efforts to streamline the approval process for new devices, enhancing market entry for innovative solutions. Key markets include Buenos Aires, Córdoba, and Mendoza, where healthcare facilities are increasingly adopting advanced technologies. The competitive landscape features major players like Abbott Laboratories and LivaNova, which are actively expanding their presence. Local market dynamics are characterized by a focus on public-private partnerships to enhance healthcare delivery. The business environment is improving, with increased investment in healthcare infrastructure and a growing emphasis on patient-centered care, creating opportunities for structural heart device manufacturers.
The Rest of South America accounts for 10.0% of the structural heart-devices market, valued at around $400 million. This sub-region includes countries like Chile, Colombia, and Peru, where the market is driven by increasing healthcare investments and a rising prevalence of cardiovascular diseases. Demand trends indicate a growing interest in minimally invasive procedures, supported by government initiatives to improve healthcare access. Regulatory frameworks are also evolving, facilitating the entry of innovative devices into these markets. Key markets include Santiago, Bogotá, and Lima, where healthcare infrastructure is gradually improving. The competitive landscape features a mix of local and international players, including Terumo Corporation and JenaValve Technology, which are expanding their footprint. Local dynamics are characterized by varying levels of healthcare access and investment, creating unique challenges and opportunities. The business environment is becoming more favorable, with increasing collaboration between governments and private sectors to enhance healthcare delivery and innovation.
The structural heart-devices market in South America is characterized by a dynamic competitive landscape, driven by increasing prevalence of cardiovascular diseases and a growing aging population. Key players such as Edwards Lifesciences (US), Medtronic (US), and Abbott Laboratories (US) are strategically positioned to leverage innovation and regional expansion. Edwards Lifesciences (US) focuses on developing advanced transcatheter heart valves, while Medtronic (US) emphasizes a broad portfolio of structural heart solutions, including minimally invasive technologies. Abbott Laboratories (US) is enhancing its market presence through strategic partnerships and acquisitions, which collectively shape a competitive environment that is increasingly focused on technological advancement and patient-centric solutions.In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is particularly crucial in a region where logistics can be challenging. The market structure appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies is significant, as they drive innovation and set industry standards, thereby shaping the overall competitive dynamics.
In October Medtronic (US) announced the launch of its new transcatheter aortic valve replacement (TAVR) system, which is designed to improve patient outcomes through enhanced delivery mechanisms. This strategic move is likely to solidify Medtronic's position as a leader in the structural heart-devices market, as it addresses the growing demand for less invasive treatment options. The introduction of this system may also enhance the company's competitive edge by appealing to healthcare providers seeking innovative solutions.
In September Abbott Laboratories (US) expanded its collaboration with a leading South American healthcare provider to enhance access to its heart valve technologies. This partnership is strategically important as it not only broadens Abbott's market reach but also aligns with the increasing emphasis on localized healthcare solutions. By fostering such collaborations, Abbott is likely to strengthen its foothold in the region and respond effectively to the unique needs of South American patients.
In August LivaNova (GB) launched a new line of heart valve products specifically tailored for the South American market, focusing on affordability and accessibility. This initiative reflects a growing trend towards addressing cost barriers in healthcare, which is particularly relevant in emerging markets. By prioritizing affordability, LivaNova may enhance its competitive positioning and appeal to a broader patient demographic, thereby contributing to its growth in the region.
As of November current trends in the structural heart-devices market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in product development and patient management. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, advanced technology, and reliable supply chains, as companies strive to meet the complex demands of the healthcare market.
Recent developments in the South America Structural Heart Devices Market have shown significant activity, with key players such as Medtronic, Abbott Laboratories, and Boston Scientific making strides in product innovation and market expansion. The demand for structural heart devices is on the rise due to the increasing prevalence of cardiovascular diseases in the region, with countries like Brazil and Argentina seeing notable growth in healthcare expenditure. In March 2023, Medtronic announced the launch of their latest transcatheter aortic valve technology in Brazil, aiming to improve treatment outcomes for patients with aortic stenosis.
Simultaneously, Abbott Laboratories has bolstered its market position by enhancing its supply chain for cardiac devices across South America, driving broader access to patients. As for mergers and acquisitions, in February 2023, Neovasc completed a strategic partnership with a local distributor in Brazil to expand their renal denervation systems. Additionally, in January 2022, Boston Scientific acquired a leading local startup specializing in minimally invasive heart valve technologies, further solidifying its presence in the region. This surge in activities is reflective of a growing market propelled by increasing healthcare investment and an aging population across South America.
The Structural Heart Devices Market is projected to grow at a 6.57% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of heart diseases, and rising healthcare expenditure.
New opportunities lie in:
By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in innovative heart solutions.
| MARKET SIZE 2024 | 77.0(USD Million) |
| MARKET SIZE 2025 | 82.06(USD Million) |
| MARKET SIZE 2035 | 155.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.57% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Edwards Lifesciences (US), Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Cardinal Health (US), LivaNova (GB), Terumo Corporation (JP), JenaValve Technology (DE), AtriCure (US) |
| Segments Covered | Type, Procedure Type, Indication, End User |
| Key Market Opportunities | Emerging technologies in minimally invasive procedures enhance growth potential in the structural heart-devices market. |
| Key Market Dynamics | Rising demand for minimally invasive procedures drives innovation in the structural heart-devices market across South America. |
| Countries Covered | Brazil, Mexico, Argentina, Rest of South America |
The market valuation was $77.0 Million in 2024.
The projected market valuation for 2035 is $155.0 Million.
The expected CAGR is 6.57% during the forecast period 2025 - 2035.
Key players include Edwards Lifesciences, Medtronic, Abbott Laboratories, Boston Scientific, and others.
Main types include Transcatheter Aortic Valve Replacement, Mitral Valve Repair Devices, and Left Atrial Appendage Closure Devices.
The valuation range for Transcatheter Aortic Valve Replacement was $30.0 Million to $60.0 Million.
The projected valuation range for Mitral Valve Repair Devices is $20.0 Million to $40.0 Million.
Primary end users include hospitals, ambulatory surgical centers, and cardiology clinics.
The valuation range for hospitals as end users was $30.0 Million to $60.0 Million.
Indications include Aortic Stenosis, Mitral Regurgitation, Heart Failure, and Pulmonary Valve Stenosis.
Kindly complete the form below to receive a free sample of this Report
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”
